All News about Relmada Therapeutics, Inc. - Common Stock![]() ![]()
Relmada Shares Nosedive As Another Depression Trial Goes Up In Smoke
December 08, 2022
Via Benzinga
![]()
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 08, 2022
Via Benzinga
![]()
Stocks That Hit 52-Week Lows On Tuesday
November 29, 2022
Via Benzinga
![]()
Relmada Stock Tumbles To 52-Week Low On Failed Depression Trial
October 13, 2022
Via Benzinga
![]() ![]()
Stocks That Hit 52-Week Lows On Friday
December 02, 2022
Via Benzinga
![]()
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022
October 14, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Recap of Tuesday's Biotech Catalysts - End Of the Day Summary
August 09, 2022
Via Benzinga
![]() Via Benzinga
Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028
May 26, 2022
Exposures
COVID-19
![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|